Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterNo recent work listed

Nan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7616-8083; OpenAlex author ID A5100332766. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 2 papers

Papers 3

  1. Chemical Exchange Saturation Transfer for Pancreatic Ductal Adenocarcinoma Evaluation. Co-author DOI 10.1097/mpa.0000000000002059↗
  2. Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2022.1007134↗
  3. Six-dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/mrm.28167↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhaoyang Fan · 3 shared papers, 2020–2022 · strength 0.37
  2. Simon K. Lo · 3 shared papers, 2020–2022 · strength 0.37
  3. Andrew Eugene Hendifar · 3 shared papers, 2020–2022 · strength 0.37
  4. Lixia Wang · 3 shared papers, 2020–2022 · strength 0.37
  5. Anthony G Christodoulou · 3 shared papers, 2020–2022 · strength 0.37
  6. Stephen Jacob Pandol · 3 shared papers, 2020–2022 · strength 0.37
  7. Srinivas Gaddam · 3 shared papers, 2020–2022 · strength 0.37
  8. Debiao Li · 3 shared papers, 2020–2022 · strength 0.37
  9. Wensha Yang · 1 shared paper, 2020 · strength 0.10
  10. Richard Tuli · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.